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Abstract
Background The discovery of an unruptured intracranial aneurysm creates a dilemma between observation and treatment.
Neurosurgeons’ routines for risk assessment and treatment decision-making are unknown. The position of evidence-based medicine
in European neurosurgery is considered to beweak, high-grade guidelines do not exist and variations between institutions are probable.
We aimed to explore European neurosurgeons’ management routines for newly discovered unruptured intracranial aneurysms.
Methods In cooperation with the European Association of Neurosurgical Societies (EANS), we conducted an online, cross-sectional
survey of 420 European neurosurgeons during Spring/Summer 2016 (1533 non-Norwegians invited through the EANS, and 16
Norwegians invited through heads of departments because of the need for additional information for a separate study). We asked
about demographic variables, routines formanagement and risk assessment of newly discovered unruptured intracranial aneurysms and
presented a case. We collected information about gross domestic product (GDP) per capita from the International Monetary Fund.
Results The response rate to the invite from the EANS was 26%, with respondents from 47 countries. More than half of the
respondents (n = 226 [54%]) reported that their department treated less than 25 unruptured aneurysms yearly. Forty percent said
their department used aneurysm size cut-off to guide treatment decisions, with a mean size of 6 mm. Presented with a case,
respondents from countries with a lower GDP per capita recommended intervention more often than respondents from higher-
income countries. Vascular neurosurgeons more commonly recommended observation.
Conclusion The answers to this self-reported survey indicate that many centers have a treatment volume lower than recommend-
ed by international guidelines, and that there are socioeconomic differences in care. Better documentation of treatment and
outcome, for example with clinical quality registries, is needed to drive improvements of care.
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[1]. This creates a dilemma as the future rupture risk of an
aneurysm must be weighed against its treatment risks.
Endovascular and surgical techniques may thus secure an an-
eurysm from future rupture, but this treatment contains a cer-
tain calculated risk.
High-grade guidelines do not exist for treatment decisions
regarding unruptured intracranial aneurysms [2–4]. Risk as-
sessment tools such as PHASES [5] (population, hyperten-
sion, age, size of aneurysm, earlier SAH from another aneu-
rysm, and site of aneurysm) score and UIATS [2] (unruptured
intracranial aneurysm treatment score) have been developed
but have been subjected to criticism. Consequently, decision-
making and advising a patient with a newly discovered intra-
cranial aneurysm largely depend on the clinicians managing
the specific patient. Which aneurysm and patient factors that
are considered most important for the rupture risk of aneu-
rysms hence differ substantially even between highly in-
formed individuals [6]. Furthermore, the position of
evidence-based medicine in European neurosurgery has been
considered to be weak, with local “house rules” taking
precedence over clinical evidence [7]. These factors
combined provide fertile ground for variations in treat-
ment between institutions. How neurosurgeons assess
risk and make treatment decisions regarding unruptured
intracranial aneurysms is largely unknown.
The aim of this study was to investigate European neuro-
surgeons’management of newly discovered unruptured intra-
cranial aneurysms. We further sought to explore possible dif-
ferences between treatment volume, geographical regions and
income levels. To this end, a self-reporting questionnaire was
developed and made available to the members of the
European Association of Neurological Surgeons (EANS)
through an online survey tool.
Methods and materials
This cross-sectional study is a cooperation between the four
neurosurgical centers treating all intracranial aneurysms in
Norway, and the EANS.
Questionnaire development
Experienced vascular neurosurgeons, epidemiologists with
experience from international surveys, and a review of rele-
vant literature formed the basis for development of a 21-item
English-language questionnaire exploring management
routines in newly discovered unruptured intracranial an-
eurysms. The questionnaire had a structured format with
closed-ended questions to maximize response rate and
ease of answering [8].
The first section examined the respondents’ age, gender,
country, type of practice, position and role in decision-making
with regard to aneurysm patients and the volume of aneurysm
patients in their department. The respondents were then asked
about the routines for discovery, risk assessment, and decision-
making with regard to newly discovered unruptured intracranial
aneurysms at their respective departments. The middle section
contained Likert-style rating questions for the respondents to
appraise the importance of different factors for decisions with
regard to risk of aneurysm rupture and treatment. The final sec-
tion contained a case, as shown in Fig. 1. The aim of the case was
not to settle a “right” answer but rather to elicit factors influenc-
ing the respondents’ answers. The complete questionnaire is
available as Electronic supplementary material 1.
Questionnaire administration
The EANS sent an e-mail during the Spring of 2016 to all of
its non-Norwegian members (n = 1533) inviting them to par-
ticipate in the survey. The survey was administered
through an online survey tool (SurveyMonkey.com,
Palo Alto, CA, USA).
The invitation e-mail informed about the aim of the survey
and provided a link where the receiver could easily indicate
whether he or she wanted to participate or not. Three and six
weeks after the first invitation, a reminder e-mail was sent to
all non-respondents who had not declined to participate.
Fig. 1 Computed tomography angiography image accompanying a case
in the questionnaire, with the following text: “In your outpatient clinic, a
65-year old male presents with an anterior communicating artery
(ACOM) aneurysm. The aneurysm has been incidentally discovered,
and has a maximal diameter of 5 mm. The aneurysm wall is somewhat
inhomogenous. The neuroradiologist informs you that endovascular
treatment is possible. The patient is diagnosed with hypertension, but
does not smoke and is otherwise healthy. He is willing to undergo
prophylactic treatment, but is not particularly anxious about the risk of
rupture in the case of abstaining from prophylactic procedures. Above is a
CTA image of the aneurysm and surrounding vasculature.”
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As additional information for a separate study was collect-
ed from Norwegian neurosurgeons, we needed to collect their
responses outside of the online tool. Therefore, the heads of
the four Norwegian neurosurgical departments received
printed versions of the survey, which they distributed
to doctors at their respective departments during
Spring/Summer 2016. The printed versions had prepaid
return envelopes enclosed.
The participants were assured that all answers would be
handled confidentially, and that they could not be traced back
to the individual respondent. Respondents could skip any
question. In accordance with Norwegian law, the study is
exempt from consideration by the committee for medical re-
search ethics as it involves no patients and/or interventions.
The study is reported according to the Strengthening the
Reporting of Observational Studies in Epidemiology
(STROBE) statement for observational studies [9].
Statistical analysis
The data were analyzed with Stata for Mac (version 15;
StataCorp LP, TX, USA). We summarized categorical
variables as percentages. Categorical variables were
compared using chi squared test. Associations between
continuous variables were explored using linear regres-
sion, and between nominal and continuous variables
using multinomial regression. A p value of < 0.05 was
assumed statistically significant. Missing items were ex-
cluded from analysis.
The practice setting was dichotomized as university
hospital or other. The respondents’ countries were
grouped into geographical regions according to United
Nations geoscheme for Europe [10]: Northern (Iceland,
Denmark, Estonia, Faroe Islands, Finland, Guernsey,
Iceland, Ireland, Isle of Man, Jersey, Latvia, Lithuania,
Norway, Sark, Svalbard and Jan Mayen, Sweden, UK),
Western (Aus t r ia , Belg ium, France, Germany,
Liechtenstein, Luxembourg, Monaco, Netherlands,
Switzerland), Southern (Albania, Andorra, Bosnia and
Herzegovina, Croat ia , Gibral tar , Greece, I ta ly,
Macedonia, Malta, Montenegro, Portugal, San Marino,
Serbia, Slovenia, Spain, Vatican City) and Eastern re-
gions (Belarus, Bulgaria, Czech Republic, Hungary,
Poland, Moldova, Romania, Russia, Slovakia, Ukraine),
as well as Others (Turkey, Israel). Gross domestic prod-
uct (GDP) per capita for 2016 for each country was
collected from the International Monetary Fund [11].
In the questionnaire, respondents were asked to provide
numbers of unruptured aneurysms evaluated and treated each
month at their department. In “Results” section, we present
these answers as numbers per year for easier comparison with
previous studies and guidelines.
Results
The EANS invited its 1533 members, of whom 404 (26%)
responded. In addition, there were 16 Norwegian respondents.
The respondents resided in 47 different countries.
Characteristics of participants and responders’
department
Table 1 describes the self-reported characteristics of respondents
and respondents’ department. The majority was male (n = 369
[88%]), worked at a university/teaching hospital (n = 314
[75%]), and the mean age was 41 years (standard deviation, ± 10).
More than half of the respondents (n = 226 [54%]) reported
that their department treated less than 25 unruptured aneu-
rysms yearly. In Southern and Eastern Europe, this treatment
volume was reported by 66% and 63%, respectively; 43% in
Northern and 40% in Western Europe (data shown in
Electronic supplementary material 2).
According to tertiles of GDP per capita, 142 of the 415 re-
spondents (34%) practiced in countries that belonged to the low-
est tertile, 191 (46%) to the middle and 82 (20%) to the highest
tertile. Electronic supplementary material 2 provides details with
regard to means and ranges of GDP per capita for the tertiles and
for the European geographical regions.
Managing routines
Seventy-eight percent of respondents said vascular teams
“mainly” or “always” make the final treatment decisions for
patients with unruptured intracranial aneurysms. Stratified by
GDP per capita tertiles, 62% of responders in the lowest tertile
said vascular teams “mainly” or “always” make these deci-
sions, in contrast to 86% and 85% for the middle and highest
tertile, respectively.
The image modalities “mainly” or “always” used to
guide treatment decisions ranged from 40% for magnet-
ic resonance angiography and 45% for 2-dimensional
digital subtraction angiography to 65% for both comput-
ed tomography angiography and 3-dimensional digital
subtraction angiography.
Tables displaying the relationships between choice of im-
age modality, GDP per capita, and European geographical
regions are provided in Electronic supplementary material 2.
Risk assessment
One hundred sixty respondents (40%) said their depart-
ment used aneurysm size cut-off to guide treatment de-
cisions, with a mean size 6 mm (SD, ± 2.4). Figure 2
visualizes the respondents’ rating of patient and aneu-
rysm factors, respectively, in assessing aneurysm rupture
risk. Previous subarachnoid hemorrhage from other
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Table 1 Characteristics of respondents and respondents’ departments




Age, mean (±SD) 41 (10)
Region
Western Europe 144 (34)
Northern Europe 65 (16)
Southern Europe 116 (28)
Eastern Europe 65 (16)
Other 30 (7)
Practice setting
University/teaching hospital 314 (75)
General/regional hospital 74 (18)
Private clinic/hospital 24 (6)
Other 8 (2)
Position and role
Head of department 72 (17)
Consultant—vascular neurosurgeon 64 (15)
Consultant—general neurosurgeon or other subspecialty 144 (34)
One of the surgeons responsible for final treatment decisions about aneurysms 65 (16)
Part of a vascular team responsible for final treatment decisions about aneurysms 89 (21)
Other* 107 (26)
Procedures that the responder performs
Surgical clipping 287 (68)
Endovascular coil 37 (9)
Endovascular stent/flow diversion 24 (6)
Bypass operation 52 (12)
Other 67 (16)
Responders’ department
Procedures performed at the department
Surgical clipping 372 (89)
Endovascular coil 364 (87)
Endovascular stent/flow diversion 309 (74)
Bypass operation 115 (27)
Other 26 (6)
No. of patients with a newly discovered unruptured aneurysm evaluated for treatment in a typical month
< 1(< 12 per year) 81 (19)
2–4(12–48 per year) 170 (41)
5–15(49-180 per year) 141 (34)
16–30(181–360 per year) 21 (5)
> 30(> 360 per year) 7 (2)
No. of patients with an unruptured aneurysm treated surgically/endovascularly in a typical month
< 1(< 12 per year) 97 (23)
1–2(12–24 per year) 129 (31)
3–5(25–60 per year) 118 (28)
6–10(61–120 per year) 59 (14)
> 10(> 120 per year) 17 (4)
The role mainly/always responsible for final treatment decisions
Vascular team 294 (78)
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aneurysms was rated as the most important patient factor,
followed by age, and family history of aneurysm/
subarachnoid hemorrhage. Sex was the only patient factor
almost uniformly reported as unimportant. Aneurysm growth
was rated as the most important aneurysm factor, followed by
size, and symptomatic aneurysm.
Fig. 2 Visualization of how respondents rated the importance of patient and aneurysm factors when assessing risk of rupture. The asterisk is aspect ratio
and similar indices
Table 1 (continued)
Variable No. of respondents (%)
Individual neurosurgeon 143 (38)
Individual neuroradiologist 76 (20)
Individual neurologist 9 (2)
No. of neurosurgeons involved in different phases of unruptured intracranial aneurysms evaluations at department, median (IQR)
Rupture risk assessment 3 (2–4)
Final treatment decisions 3 (2–4)
Surgical/endovascular treatment 3 (2–4)
Normal waiting times, median no. of weeks (IQR)
From reception of referral and to patient is seen in outpatient clinic 2 (1–4)
From the patient is seen in outpatient clinic to final treatment 4 (2–6)
Does the department use aneurysm size cut-off to guide treatment decisions? 166 (40)
Cut-off size for departments that used such, mean (±SD) 6.0 (2.4)
Respondents could skip any question. The reported percentages are calculated from the number of respondents for each question
IQR interquartile range, SD standard deviation.
* Eighty-seven of these specified that they were residents or similar terms
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Case answers according to geographical region and
gross domestic product per capita
Presented with a case of a 65-year-old male with an inciden-
tally discovered 5-mm anterior communicating artery aneu-
rysm, 87 of 351 respondents (25%) chose either
“Observation with lifestyle changes” or “No further follow-
up needed” whereas 264 (75%) advised intervention
(endovascular or surgical prophylactic treatment). Figure 1
provides case details.
With regard to geographical region, 45% of the respon-
dents from Northern Europe recommended observation or
no follow-up compared with 13% from Southern Europe.
The proportion of respondents recommending observation or
no follow-up increased with the GDP per capita. These an-
swers are visualized in Fig. 3, and absolute numbers of re-
spondents are provided in Electronic supplementary material
2. Multinomial regression analysis of country categories and
GDP per capita was statistically significant with a p value <
0.001 and an R2 of 0.53, suggesting that 53% of the variance
in one of these two variables is explained by the variance in
the other variable. Case answers and treatment volume were
not statistically significantly associated (p = 0.52).
Twenty-one percent of respondents characterized them-
selves as vascular neurosurgeons. Forty-two percent of these
recommended observation or no follow-up, compared with
21% among other respondents (p = 0.001). No statistically
significant differences between vascular and non-vascular
neurosurgeons was regarding the use of size cut-off (p = 0.83).
Discussion
In this survey, more than half of the respondents reported that
their department treated 0–25 unruptured aneurysms per year.
Forty percent of respondents said their department used aneu-
rysm size cut-off to guide treatment decisions. Presented with
a case, respondents from countries with a lower GDP per
capita recommended intervention more often than respon-
dents from richer countries.
Treatment volume
Guidelines from the American Heart Organization/American
Stroke Organization recommends surgical treatment of
unruptured aneurysms only in centers performing > 20 cases
of unruptured aneurysms annually [4]. Thus, surprisingly
many in our survey report a volume so low that treatment
quality can be questioned. A Scandinavian study showed a
trend towards lower 1-year mortality with higher treatment
volume for unruptured intracranial aneurysms, but not for
ruptured ones [12]. The authors hypothesized that surgical
experience was more directly associated with outcome after
treatment of unruptured aneurysms because these patients
were otherwise healthy and underwent planned surgery [12].
As detailed in Electronic supplementary material 2, respon-
dents from Southern and Eastern Europe reported lower treat-
ment volumes. This finding warrants an open and thorough
documentation of treatment and outcome.
Fig. 3 Case answers by
geographical region and gross
domestic product per capita
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Aneurysm size cut-off and rating of risk factors
Almost half of the respondents reported that their department
uses aneurysm size cut-off to guide treatment decisions, with a
mean size of 6 mm. Surprisingly, this is smaller than the 7-mm
cut-off often used in the literature [5, 13]. Though one of the
most important risk factors for rupture, aneurysm size in itself
is a parameter with low sensitivity and specificity for rupture
[14, 15]. Relying too much on aneurysm size may thus cause
overtreatment of large but benign aneurysms, and
undertreatment of small but dangerous ones. In addition to
patient factors, treatment decisions can be supported by aneu-
rysm factors such as morphology and hemodynamics [2,
16–18], and magnetic resonance vessel wall imaging [19, 20].
Among patient-related risk factors, the respondents rated
smoking as third lowest, and sex as least important. This is in
stark contrast to previous literature, which has established that
the most important risk factors for aneurysm rupture are
smoking, hypertension, and female sex (especially postmeno-
pausally), and that these three risk factors account for most of
the variation in the incidence of aneurysmal SAH [21].
We do not know whether the respondents regard sex as an
unimportant risk factor, or simply that they do not emphasize
this risk factor when consulting individual patients. Similarly,
we do not know how strictly the respondents use a size cut-off,
and the survey question did not permit respondents to differ-
entiate according to aneurysm location. Still, the respondents’
rating of risk factors and the large proportion of respondents
that report using a cut-off size of 6 mm is an opportunity to
encourage the neurosurgical community to ensure an
evidence-based risk assessment, incorporating both aneurysm
and patient-related factors [3, 4].
Socioeconomic and regional differences
There was a clear association between a lower GDP per capita
of respondents’ countries and a higher tendency to recom-
mend intervention, when presented with the case of an inci-
dentally discovered unruptured anterior communicating artery
aneurysm. Treatment volume was not statistically significant-
ly associated with different case answers. The proportion of
respondents that said treatment decisions were taken by teams
rather than individual doctors was higher in countries with
middle and high GDP per capita. This leads to increased ex-
penses bymeans of costly working hours of highly specialized
personnel but hopefully also to better overall decisions and
more efficient patient care pathways, incorporating a complex
multifactorial assessment and less use of individual biases. As
shown in Electronic supplementary material 2, respondents
from countries with a higher GDP use magnetic reso-
nance angiography and 3-dimensional digital subtraction
angiography more often than respondents from countries
with lower GDP per capita.
We are unaware of other questionnaire-based studies about
the management of unruptured aneurysms except expert opin-
ions [2], but clinical patient series support our findings of socio-
economic and geographical differences. A retrospective chart
review of 424 consecutive patients with unruptured intracranial
aneurysms managed in a single US center investigated factors
associated with treatment (163 patients) versus observation (261
patients). As expected, younger patients, a lower Charlson
Comorbidity Index, a larger aneurysm size and multiple aneu-
rysms were associated with the decision to treat rather than to
observe. Unexpectedly, a white race and living further from the
medical center were also associated with a decision to treat [22].
Data from 57,000 unruptured intracranial aneurysms (18,000
treated) from the US National Inpatient Sample Database
2000–2010 showed that patients with private insurance coverage
and white race were more likely to undergo treatment [23]. The
external validity of these findings from the US health system
(with a non-universal insurance system) on European health sys-
tems (with mostly government-funded or universal public insur-
ance systems) is unknown [24].
Vascular neurosurgeons
Twenty-one percent (n = 89) of respondents characterized
themselves as vascular neurosurgeons, and the survey answers
thus reflect opinions from doctors with varying experience
with the decision-making in intracranial aneurysms.
Presented with the case, the vascular neurosurgeons more
commonly recommended observation. However, the propor-
tion of vascular neurosurgeons was higher in the highest GDP
tertile, and in Northern Europe (data not shown), and we can-
not exclude confounding from these factors.
Implications
We have found that the management of unruptured intracra-
nial aneurysms is unequal across Europe. A self-reported sur-
vey, though prone to response bias, is a swift way to obtain
data from many subjects and create an overview over an area
of study. The response rate of 26% is good compared with
many other surveys of doctors [7, 25], but we still consider it
low. We are unable to verify the self-reported treatment vol-
ume with actual numbers of treated patients, and whether the
actual treatment volume is sufficient for treatment and training
quality. Therefore, the findings of questionably low treatment
volumes and socioeconomic differences warrant further inves-
tigation. The survey detects a possible difference between the
answers of vascular and non-vascular neurosurgeons, which
needs further exploration. We will argue that all institutions
treating intracranial aneurysms should report results
openly to clinical quality registries, in order to aid com-
parisons and systematically drive improvements of the
care quality across the entire region [26].
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Conclusions
According to answers in this self-reported survey, treatment of
unruptured intracranial aneurysms in Europe is frequently per-
formed in centers with low treatment volumes. Treatment de-
cisions vary in relation to gross domestic product per capita
and geographical regions. The treatment of unruptured intra-
cranial aneurysms in Europe should be documented better,
preferably by incorporating clinical quality registries.
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